A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss

Inclusion Criteria: * Male and female volunteers 18 to 65 years old, inclusive * Hair loss consistent with ≥ Grade III-Vertex, IV, VA, V, and VI, based on Norwood-Hamilton Scale providing there is bridging of hair in the anterior edge of the vertex circle. * Have no clinically significant disease or abnormal laboratory results taken at the screening visit. Exclusion Criteria: * Known sensitivity to DMEM/F-12 or any component of the study material. * Known hypersensitivity to clindamycin hydrochloride, amphotericin B or streptomycin sulfate. * Subjects who have used minoxidil, or any oral or topical medication including over the counter and herbal medications for the treatment of hair loss within 6 months of study screening, or finasteride or dutasteride within 12 months of study screening. * A history of drug or alcohol abuse within 1 year of study enrollment. * Clinically significant medical or psychiatric illness currently or within 30 days of study screening as determined by the investigator. * Any clinically significant abnormal laboratory parameters. * A positive result at screening for human immunodeficiency virus (HIV 1 or 2), Hepatitis B or C, HTLV I/II. * Dermatologic condition in donation and/or study areas. * Prior surgery in the treatment area. * Insufficient hair or scarring in the donor area that might impact cell growth. * Any disease or condition (medical or surgical) that, in the opinion of the investigator, might compromise hematologic, cardiovascular, pulmonary, renal, gastrointestinal, hepatic, or central nervous system function; or any condition that would place the subject at increased risk.